2013 parkinson's disease glutathione 2013 four authors Enhanced accumulation of reduced by Scopoletin improves survivability of dopaminergic neurons in model Potential use of glutathione as
Description
Injected every 12 weeks into specific points around the head and neck to significantly reduce migraine frequency
This paper demonstrated that the oxPPP is not required for tumour growth in several cancer models
Hwang PM, Pan JS, Sykes BD
doi:10.1038/363449a0
